HESI Pharmacology IV Exam

Correct Answer C: The medication will permanently stain my skin.

Explanation of the Correct Answer:

C. The medication will permanently stain my skin. is correct because this statement indicates a lack of understanding about silver sulfadiazine (Silvadene). While this topical antimicrobial cream can cause temporary discoloration of the skin due to its silver content, it does not cause permanent staining. Any discoloration typically fades with cleansing and healing of the wound. Silver sulfadiazine is well-known for its broad-spectrum antimicrobial properties, especially against gram-negative and gram-positive organisms, and is widely used in partial-thickness and full-thickness burns. However, misconceptions like permanent staining indicate the need for further client education.

Why the other options are incorrect:

A. The medication is an antibacterial. is incorrect because this statement is true. Silver sulfadiazine acts as a topical antibacterial agent, particularly effective against a wide range of pathogens including Pseudomonas aeruginosa, a common gram-negative organism found in burn wounds. It helps reduce the risk of wound sepsis and promotes a more sterile healing environment.

B. The medication will help heal the burn. is incorrect because this statement is accurate. Silver sulfadiazine not only prevents infection but also supports the healing process by keeping the wound environment moist and free from microbial invasion. This contributes to more favorable wound healing outcomes.

D. The medication should be applied directly to the wound. is incorrect because this is the correct method of application. Silver sulfadiazine should be applied in a thin, even layer directly to the burn wound after cleansing, typically 1 to 2 times daily. It may be covered with sterile dressing or left open to air depending on the treatment plan.

Summary:

The client’s statement about permanent skin staining reflects a misunderstanding of silver sulfadiazine’s effects. While temporary discoloration can occur, it is not permanent and should not be a concern. The nurse should clarify this misconception and reinforce accurate information regarding the medication’s purpose, application, and expected outcomes to ensure proper treatment adherence and reduce unnecessary anxiety.

Correct Answer C: Reduction of steatorrhea

Explanation of the Correct Answer:

C. Reduction of steatorrhea is correct because pancrelipase (Pancrease MT) is a pancreatic enzyme replacement therapy used to aid digestion in clients with pancreatic insufficiency, which occurs in conditions such as cystic fibrosis or chronic pancreatitis. Steatorrhea, characterized by fatty, foul-smelling stools, occurs due to the inability to properly digest and absorb fats because of insufficient pancreatic enzymes. Pancrelipase helps break down fats, proteins, and carbohydrates, and the optimal intended benefit of this medication is the reduction or resolution of steatorrhea as the body can now properly digest fats.

Why the other options are incorrect:

A. Weight loss is incorrect because pancrelipase is not intended to cause weight loss. In fact, by improving digestion and nutrient absorption, pancrelipase can potentially help prevent weight loss that may occur due to malabsorption of nutrients in clients with pancreatic insufficiency. Weight loss is not the desired outcome, and weight gain or maintenance is more typical as digestion improves.

B. Relief of heartburn is incorrect because pancrelipase does not address issues related to acid reflux or heartburn. Heartburn is generally managed with antacids, H2 blockers, or proton pump inhibitors (PPIs), not pancrelipase. The primary function of pancrelipase is aiding the digestion of fats, proteins, and carbohydrates, not alleviating acid reflux symptoms.

D. Absence of abdominal pain is incorrect because while pancrelipase may help with digestion and reduce symptoms such as bloating or discomfort caused by malabsorption, it is not specifically targeted at relieving abdominal pain. Abdominal pain in conditions like pancreatic insufficiency may require other interventions depending on the underlying cause, but pancrelipase is primarily focused on improving nutrient digestion, not directly alleviating pain.

Summary:

The optimal benefit of pancrelipase (Pancrease MT) is seen in the reduction of steatorrhea, as the medication aids in the digestion and absorption of fats, proteins, and carbohydrates. It does not directly cause weight loss, relieve heartburn, or necessarily eliminate abdominal pain, although it can improve overall digestion and prevent complications related to malabsorption.

Correct answer A: It facilitates the transport of glucose into the cells.

Explanation of the correct answer:

A. It facilitates the transport of glucose into the cells.

Neutral protamine Hagedorn (NPH) insulin is an intermediate-acting insulin that works by lowering blood glucose levels by facilitating the transport of glucose into the cells. NPH insulin is absorbed more slowly and has a longer duration of action compared to short-acting insulins, and its primary action is to mimic the pancreas' ability to regulate glucose in the body. When administered, NPH insulin helps the body use glucose for energy by facilitating the entry of glucose into muscle and fat cells, which is essential for energy production.

Why the other options are incorrect:

B. It stimulates the function of beta cells in the pancreas.

NPH insulin does not stimulate the pancreas' beta cells. The pancreas' beta cells are responsible for producing insulin, but NPH insulin is an external source of insulin that works independently of the pancreas to help regulate blood glucose levels. It does not have a direct effect on the function of beta cells.

C. It increases the intracellular receptor site sensitivity.

NPH insulin does not directly increase receptor site sensitivity. It works by promoting glucose uptake into the cells. Sensitivity of insulin receptors is typically influenced by factors such as exercise and weight management, rather than the type of insulin being used.

D. It delays the carbohydrate digestion and absorption.

NPH insulin does not affect carbohydrate digestion or absorption. Its action is focused on facilitating glucose transport into cells. Medications like alpha-glucosidase inhibitors (e.g., acarbose) are used to delay the digestion and absorption of carbohydrates, but NPH insulin does not have this effect.

Summary:

NPH insulin helps to facilitate the transport of glucose into cells to lower blood sugar levels, which is crucial for managing Type 1 diabetes. Therefore, the statement "It facilitates the transport of glucose into the cells" indicates the correct understanding of how NPH insulin works.

Correct Answer C: The medications will kill the bacteria and stop the acid production.

Explanation of the Correct Answer:

C. The medications will kill the bacteria and stop the acid production." is correct because the prescribed regimen of clarithromycin (Biaxin), esomeprazole (Nexium), and amoxicillin (Amoxil) is a triple therapy commonly used to treat Helicobacter pylori infections in the treatment of peptic ulcers.

Clarithromycin and amoxicillin are antibiotics that work to kill the H. pylori bacteria, which is the underlying cause of the infection.

Esomeprazole, a proton pump inhibitor (PPI), works by reducing gastric acid production, which helps heal the ulcer and creates an environment less conducive to bacterial growth. This combination of medications addresses both the bacterial infection and the excessive acid production, leading to healing of the ulcer.

Why the other options are incorrect:

A. My ulcer will heal because these medications will kill the bacteria.

This statement is partially correct because the antibiotics do kill the bacteria, but it overlooks the important role of esomeprazole in reducing acid production, which is essential for healing the ulcer. The ulcer would not heal properly if acid production is not controlled.

B. These medications are only taken when I have pain from my ulcer.

This statement is incorrect because the medications in the regimen are meant to be taken regularly as prescribed, not on an as-needed basis. The antibiotics and PPI work best when taken consistently, and stopping them after pain resolves can result in incomplete treatment of the H. pylori infection, leading to potential recurrence.

D. The medications will coat the ulcer and decrease the acid production in my stomach.

 This statement is incorrect because none of the medications in the prescribed regimen (clarithromycin, amoxicillin, or esomeprazole) coat the ulcer. Esomeprazole reduces acid production, but it does not coat the ulcer. The ulcer healing is more related to reducing acid production and eliminating the bacteria.

Summary:

The correct statement reflects the dual action of the prescribed regimen for treating the Helicobacter pylori infection: it addresses the bacterial infection with antibiotics (clarithromycin and amoxicillin) and controls gastric acid production with esomeprazole, allowing the ulcer to heal.

Correct answer B: 10 to 20 mcg/mL

Explanation of the correct answer:

B. 10 to 20 mcg/mL

Phenytoin (Dilantin) is an anticonvulsant used to manage and prevent seizures. It has a narrow therapeutic index, which means that blood levels must be carefully monitored to ensure effectiveness without causing toxicity. The therapeutic serum level for phenytoin is 10 to 20 mcg/mL. Within this range, the drug is typically effective in controlling seizures while minimizing the risk of side effects. Levels below 10 mcg/mL may result in inadequate seizure control, while levels above 20 mcg/mL increase the risk for toxicity, which can cause symptoms such as nystagmus, ataxia, slurred speech, confusion, lethargy, and potentially life-threatening cardiac arrhythmias.

Why the other options are incorrect:

A. 5 to 10 mcg/mL

This range is below the therapeutic level and may be insufficient to control seizures, putting the client at risk for breakthrough seizure activity.

C. 20 to 30 mcg/mL

This range is above the therapeutic level and increases the risk for phenytoin toxicity. Levels greater than 20 mcg/mL can lead to central nervous system and cardiovascular side effects.

D. 30 to 40 mcg/mL

This range is considered toxic and poses a serious risk to the client. At this level, immediate medical intervention is necessary to prevent life-threatening complications.

Summary:

A serum phenytoin level between 10 to 20 mcg/mL is considered therapeutic and safe for most clients. Monitoring this range is essential for ensuring the medication is both effective and non-toxic.

Correct answer  C: Elevated blood urea nitrogen level

Explanation of the correct answer:

C. Elevated blood urea nitrogen level

Cyclosporine is an immunosuppressant used to prevent rejection in organ transplant patients. A well-known adverse effect of cyclosporine is nephrotoxicity. Elevated blood urea nitrogen (BUN) is a common early indicator of reduced kidney function and potential toxicity. Monitoring kidney function is crucial when a client is taking cyclosporine, as continued nephrotoxicity can lead to permanent renal damage.

Why the other options are incorrect:

A. Decreased creatinine level

This would actually be a positive finding, as it suggests good kidney function. A concerning result would be increased creatinine, not decreased, because that would also point to impaired renal function.

B. Decreased hemoglobin level

While cyclosporine can, in rare cases, lead to anemia, a decrease in hemoglobin is not a primary or most concerning adverse effect. It is less directly linked to the known toxicity profile of cyclosporine.

D. Decreased white blood cell count

Cyclosporine suppresses T-cell activity but does not significantly reduce overall white blood cell count like other immunosuppressants such as azathioprine or mycophenolate. Therefore, this is not the best indicator of a cyclosporine-related adverse effect.

Summary:

An elevated BUN level is a critical lab finding when monitoring for adverse effects of cyclosporine. It reflects possible nephrotoxicity, which is a dose-limiting and serious complication associated with this drug.

Correct answer B: The infection is difficult to eradicate and requires prolonged therapy for 3 to 6 months.

Explanation of the correct answer:

Onychomycosis, a fungal infection of the nails, often requires prolonged treatment because the infection can be deeply embedded in the nail, and the nail grows slowly. Oral antifungal therapy, such as terbinafine or itraconazole, is typically needed for 3 to 6 months to ensure complete eradication of the infection. The medication helps to clear the infection by gradually eradicating the fungus from the nail bed and surrounding tissue.

Why the other options are incorrect:

A. A single dose of the oral antifungal agent is usually sufficient to treat the infection:

This is incorrect. Onychomycosis is a chronic infection that requires long-term treatment to effectively clear the infection. A single dose is typically not sufficient, as the medication needs time to work through the nail bed and surrounding tissue.

C. Complete eradication is important because of the risk of a systemic infection:

While it's important to treat onychomycosis thoroughly to avoid recurrence and complications, systemic infections from onychomycosis are rare. The primary goal is to treat the fungal infection locally and prevent it from spreading or causing further nail damage.

D. Prolonged therapy provides no benefit and increases the risk of adverse effects:

This is not accurate. Prolonged therapy is necessary for treating onychomycosis effectively. While there are risks associated with prolonged antifungal treatment, such as liver toxicity or gastrointestinal side effects, the benefit of eradicating the infection outweighs these risks when monitored appropriately.

Summary:

Onychomycosis is a fungal infection that often requires prolonged therapy, typically lasting 3 to 6 months, to fully treat the infection. This prolonged therapy is necessary to allow the medication to penetrate the nail bed and eradicate the fungus effectively.

Correct answer B: Decreased muscle spasms

Explanation of the correct answer:

B. Decreased muscle spasms

Baclofen (Lioresal) is a muscle relaxant and antispasmodic medication that is commonly prescribed to patients with multiple sclerosis (MS) to manage spasticity and muscle spasms. The primary therapeutic effect of baclofen is to decrease muscle spasms by acting on the central nervous system (CNS), specifically the GABA receptors in the spinal cord. This leads to a reduction in the frequency and severity of involuntary muscle contractions associated with spasticity, which is a common symptom of MS. Baclofen helps to improve mobility and comfort in clients with MS who experience these muscle spasms.

Why the other options are incorrect:

A. Increased muscle tone

Baclofen does not increase muscle tone. In fact, it is used to decrease muscle tone by reducing spasticity and muscle spasms. It works by inhibiting excessive neuronal activity that leads to the increased muscle tone seen in conditions like MS.

C. Increased range of motion

While baclofen may help improve mobility by decreasing muscle spasms and stiffness, increased range of motion is not the primary therapeutic effect of the medication. Baclofen primarily focuses on reducing spasms rather than directly improving the flexibility or movement of joints.

D. Decreased local pain and tenderness

Baclofen is not primarily used for pain management. It is an antispasmodic, not an analgesic, so its effect on pain and tenderness is secondary to its main function of reducing muscle spasms. Pain relief may occur as a secondary benefit if muscle spasms are contributing to discomfort, but this is not the primary goal of treatment with baclofen.

Summary:

Baclofen is primarily used to decrease muscle spasms in clients with multiple sclerosis by acting on the CNS to reduce spasticity. It is not intended to increase muscle tone, directly increase range of motion, or primarily reduce pain.

Correct Answer D:  At least 30 minutes before exposure to the sun

Explanation of the Correct Answer:

D. At least 30 minutes before exposure to the sun is correct because chemical sunscreens need time to be absorbed into the skin to become effective. Chemical sunscreens work by absorbing ultraviolet (UV) radiation and converting it into heat, a process that requires the active ingredients to bind adequately to the skin. The general recommendation is to apply these sunscreens at least 15 to 30 minutes before sun exposure, with 30 minutes being the most effective timeframe to ensure maximum protection.

Why the other options are incorrect:

A. Immediately before swimming is incorrect because sunscreen applied just before entering the water may not have enough time to absorb into the skin, reducing its effectiveness and increasing the risk of it washing off.

B. 15 minutes before exposure to the sun is not the best answer because although some sources state that 15 minutes may be sufficient for certain formulations, 30 minutes is the widely accepted standard for optimal absorption and protection, especially for chemical sunscreens.

C. Immediately before exposure to the sun is incorrect because immediate application does not allow enough time for the sunscreen to bind properly to the skin, which can compromise its ability to protect effectively from UV radiation.

Summary:

Chemical sunscreens are most effective when applied at least 30 minutes before sun exposure, allowing sufficient time for absorption and optimal UV protection. Applying sunscreen too close to sun or water exposure reduces its effectiveness and increases the risk of sunburn. Therefore, the nurse is correct in advising early application.